Eu approval date sugammadex?

What is the EU approval date for sugammadex?

Sugammadex (Bridion) received European Union marketing authorization on 20 May 2008. [1]

When did sugammadex first get approved in Europe?

The first EU approval is the marketing authorization date above (20 May 2008). [1]

What should I search if I need the exact EMA approval details?

If you need the formal EMA record (procedure type, product name, applicant/company, and specific decision date), the best starting point is the EMA marketing authorization page or the product’s EPAR (European Public Assessment Report), using the date 20 May 2008 as the anchor. [1]

Is the approval date the same as launch or generic availability?

No. The EU approval date is the authorization for marketing; actual commercial launch and later generic/biosimilar entry depend on distribution, pricing/reimbursement timelines, and patent/exclusivity and legal status after approval. (For patent/exclusivity timelines, see DrugPatentWatch.) [2]

Sources:
[1] https://www.drugs.com/history/sugammadex.html
[2] https://www.drugpatentwatch.com/